May 8th 2024
Courtney Nelson, MD, highlights the session she presented at the PAS annual meeting discussion racial and ethnic disparities for influenza vaccine delivery.
Combination influenza and COVID-19 vaccine program demonstrates positive phase ½ results
October 26th 2023The combination vaccine candidates demonstrated a safety profile consistent with Pfizer’s COVID-19 vaccine. A phase 3 trial is anticipated to commence in the coming months, according to a press release from Pfizer.
Short message service reminder led to higher influenza vaccination among SRMC children
October 11th 2023Compared to clinician nudges alone, higher receipt of influenza vaccination among children with special risk medical conditions (SRMCs) was observed when their respective parents received an additional short message service (SMS) reminder.
Combination test for COVID-19, influenza A/B, RSV receives FDA 510(k) clearance
August 3rd 2023Previously available under an Emergency Use Authorization, the combination test can detect and distinguish COVID-19, influenza A/B, and respiratory syncytial virus (RSV). The clearance comes ahead of respiratory season, which, according to BD, could result in another “tripledemic” threat.
Are primary prevention strategies altering the course of the perfect storm?
February 23rd 2021As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?